129 related articles for article (PubMed ID: 30074239)
1. Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group.
Klein K; Hasle H; Abrahamsson J; De Moerloose B; Kaspers GJL
Br J Haematol; 2018 Oct; 183(1):87-95. PubMed ID: 30074239
[TBL] [Abstract][Full Text] [Related]
2. International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia.
Lehrnbecher T; Ethier MC; Zaoutis T; Creutzig U; Gamis A; Reinhardt D; Aplenc R; Sung L
Br J Haematol; 2009 Oct; 147(1):125-8. PubMed ID: 19663826
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Al Omar S; Anabtawi N; Al Qasem W; Rihani R
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
[TBL] [Abstract][Full Text] [Related]
4. Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.
Tramsen L; Salzmann-Manrique E; Bochennek K; Klingebiel T; Reinhardt D; Creutzig U; Sung L; Lehrnbecher T
J Clin Oncol; 2016 Aug; 34(23):2776-83. PubMed ID: 27269945
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Sung L; Aplenc R; Alonzo TA; Gerbing RB; Lehrnbecher T; Gamis AS
Blood; 2013 May; 121(18):3573-7. PubMed ID: 23471307
[TBL] [Abstract][Full Text] [Related]
7. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Gerber B; Köppel J; Paul M; Nguyen-Kim TD; Frauenfelder T; Nair G; Schanz U; Manz MG
Swiss Med Wkly; 2014; 144():w13985. PubMed ID: 25055166
[TBL] [Abstract][Full Text] [Related]
9. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
10. Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.
Lehrnbecher T; Sung L
Expert Rev Hematol; 2014 Dec; 7(6):819-30. PubMed ID: 25359519
[TBL] [Abstract][Full Text] [Related]
11. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.
Bochennek K; Hassler A; Perner C; Gilfert J; Schöning S; Klingebiel T; Reinhardt D; Creutzig U; Lehrnbecher T
Blood Cancer J; 2016 Jan; 6(1):e382. PubMed ID: 26771808
[TBL] [Abstract][Full Text] [Related]
12. Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
Cernan M; Szotkowski T; Hubacek J; Kolar M; Faber E; Indrak K; Papajik T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):236-245. PubMed ID: 35258041
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.
Hammond SP; Baden LR
Curr Hematol Malig Rep; 2007 May; 2(2):97-103. PubMed ID: 20425357
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial prophylaxis for gram-positive and gram-negative infections in cranial surgery: A meta-analysis.
Abraham P; Lamba N; Acosta M; Gholmie J; Dawood HY; Vestal M; Huang K; Hulou M; Asgarzadeh M; Zaidi H; Mekary RA; Smith TR
J Clin Neurosci; 2017 Nov; 45():24-32. PubMed ID: 28802796
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
[TBL] [Abstract][Full Text] [Related]
16. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
[TBL] [Abstract][Full Text] [Related]
17. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
19. SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Busca A; Lessi F; Verga L; Candoni A; Cattaneo C; Cesaro S; Dragonetti G; Delia M; De Luca A; Guglielmi G; Tumbarello M; Martino G; Nadali G; Fanci R; Picardi M; Potenza L; Nosari A; Aversa F; Pagano L;
Leuk Lymphoma; 2017 Dec; 58(12):2859-2864. PubMed ID: 28508692
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Measures During Induction for Acute Myeloid Leukemia.
McCarthy MW; Walsh TJ
Curr Oncol Rep; 2017 Mar; 19(3):18. PubMed ID: 28251490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
